BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today the nationwide availability of a suite of tests to identify patients with BRCA mutations who are at increased risk for breast, ovarian and other cancers. The BRCAssure tests will be available through LabCorp as well as Integrated Genetics and Integrated Oncology, members of LabCorp’s Specialty Testing Group.
Help employers find you! Check out all the jobs and post your resume.
